Jane Street’s Tenaya Therapeutics TNYA Stock Holding History

Jane Street’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.5K	Sell	29,600 -98,500	-77%	-$72.7K	﹤0.01%	11188
2025 Q4	$91.1K	Buy	128,100 +69,400	+118%	+$94.4K	﹤0.01%	10231
2025 Q3	$95.1K	Buy	+58,700	New	+$59.1K	﹤0.01%	10160
2023 Q4	–	Sell	-12,000	Closed	-$30.6K	–	9811
2023 Q3	$30.6K	Sell	12,000 -50,200	-81%	-$210K	﹤0.01%	8243
2023 Q2	$365K	Buy	+62,200	New	+$361K	﹤0.01%	6820

Other funds holding TNYA

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BGM

Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $141M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street's TNYA Position: Q1 2026 in Review

Jane Street increased its Tenaya Therapeutics (TNYA) stake by 74% in Q1 2026, buying an estimated $370K and bringing the position to 1,180,081 shares worth $817K. The position accounts for ﹤0.01% of the portfolio, ranked #6937.

Jane Street first reported a position in TNYA in Q4 2022 and has held it in 13 quarters since. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

Jane Street held 1,180,081 shares of Tenaya Therapeutics worth $817K as of Q1 2026.
Jane Street bought 501,621 Tenaya Therapeutics shares in Q1 2026, an estimated $370K.
Tenaya Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #6937 holding.
Jane Street first reported a position in Tenaya Therapeutics in Q4 2022 and has held it in 13 quarters since.
103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.